Our Latest Stories

Our Science
May 28, 2025
A New Era of Biopharma Production with AI

United by Purpose
Each of us plays a unique role in bringing our purpose to life.
About Us

Who We Are
We are an R&D driven,
AI-powered biopharma company committed to improving people’s lives and creating compelling growth.
Our Pipeline
5
Therapeutic areas
86
Compounds in clinical development
24
Clinical trials in phase 3

Pursue Progress. Discover Extraordinary.
Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.
Our Latest Press Releases
June 3, 2025
Press Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector
June 3, 2025
Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
June 2, 2025
Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
May 30, 2025
Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies